The purpose of Core A is to coordinate the administrative function of the Program Project and to foster a highly communicative, collaborative, and enthusiastic atmosphere to promote the science proposed in this application. Dr, Hanein, the PI of the core, will be responsible for the overall administration and supervision of this Program Project. Dr. Hanein will be assisted by an administrative assistant, Ms. Debbie Signer, provided by SBIMR, who will serve as the Administrator for the Program Project. Core A will serve as the interface of contact between the institutions (SBIMR, UCSD, UVA and Harvard), the 7 investigators, and all other personnel involved, as well as with the NIGMS. The six ether project leaders and co-investigators will receive funding via subcontracts issued by SBMRI, and each project leader and co-lnvestigator will be responsible for the day to day administration of the funds and the scientific oversight of the research. All Pis are highly motivated, successful scientists, so there is no anticipated need for a high level ef supervision. However, to track progress and, more importantly, to share new results and provide advice, all Pis will submit brief progress reports at monthly conference calls. Based on these reports and discussions, if there is any problem with productivity or management issues. Dr. Hanein, in consultation with the steering committee will work closely with any lab experiencing problems to put things back on the right track. Again, given the scientific experience and productivity of the individuals, this is highly unlikely. Core A will provide all coordination of collaborative meetings, organize regular meetings and reviews of the projects and cores (at least once a year), maintain contact with the Scientific Advisory Beard (SAB), organize the annual scientific retreat with the SAB and facilitate training of junior scientists. In addition to these responsibilities, the administrative core will oversee budget management for the Program Project, assist in the preparation of publications, and maintain the Program Project's website.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-GDB-8 (IP))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
United States
Zip Code
Choi, Jiho; Clement, Kendell; Huebner, Aaron J et al. (2017) DUSP9 Modulates DNA Hypomethylation in Female Mouse Pluripotent Stem Cells. Cell Stem Cell 20:706-719.e7
Merkle, Florian T; Ghosh, Sulagna; Kamitaki, Nolan et al. (2017) Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545:229-233
Smith, Zachary D; Shi, Jiantao; Gu, Hongcang et al. (2017) Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer. Nature 549:543-547
Melé, Marta; Mattioli, Kaia; Mallard, William et al. (2017) Chromatin environment, transcriptional regulation, and splicing distinguish lincRNAs and mRNAs. Genome Res 27:27-37
Lin, Shuibin; Choe, Junho; Du, Peng et al. (2016) The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell 62:335-345
Groff, Abigail F; Sanchez-Gomez, Diana B; Soruco, Marcela M L et al. (2016) In Vivo Characterization of Linc-p21 Reveals Functional cis-Regulatory DNA Elements. Cell Rep 16:2178-2186
Santos, David P; Kiskinis, Evangelos; Eggan, Kevin et al. (2016) Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol 38:5B.6.1-5B.6.60
Hacisuleyman, Ezgi; Shukla, Chinmay J; Weiner, Catherine L et al. (2016) Function and evolution of local repeats in the Firre locus. Nat Commun 7:11021
Liu, Lin L; Brumbaugh, Justin; Bar-Nur, Ori et al. (2016) Probabilistic Modeling of Reprogramming to Induced Pluripotent Stem Cells. Cell Rep 17:3395-3406
Tsankov, Alexander M; Akopian, Veronika; Pop, Ramona et al. (2015) A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells. Nat Biotechnol 33:1182-92

Showing the most recent 10 out of 55 publications